US 12,285,428 B2
Methods of treating kidney conditions using modified forms of trimetazidine
Paul Chamberlin, Brookline, MA (US)
Assigned to IMBRIA PHARMACEUTICALS, INC., Boston, MA (US)
Filed by IMBRIA PHARMACEUTICALS, INC., Boston, MA (US)
Filed on Nov. 27, 2023, as Appl. No. 18/519,782.
Application 18/519,782 is a continuation of application No. 17/735,594, filed on May 3, 2022, granted, now 11,883,396.
Claims priority of provisional application 63/183,303, filed on May 3, 2021.
Prior Publication US 2024/0091222 A1, Mar. 21, 2024
Int. Cl. A61K 31/496 (2006.01); A61P 13/12 (2006.01)
CPC A61K 31/496 (2013.01) [A61P 13/12 (2018.01)] 20 Claims
 
1. A method of increasing ATP production in a kidney of a subject, the method comprising providing to a subject having a kidney condition a composition comprising a compound of formula (IX):

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.